摘要
糖尿病已成为严重危害人类健康的慢性疾病，研究开发新型的抗糖尿病药物是全球医药工作者面临的重要课题。截至目前，全球各医药企业以胰岛素受体激动剂、胰高血糖素样肽-1激动剂、二肽基肽酶4抑制剂、胰岛素增敏剂为重点对治疗I型和II型糖尿病在内的1400余种药物进行了开发。文章重点对抗II型糖尿病药物开发的主要靶标、开发企业及市场前景进行了分析。
出处
《生物产业技术》
2014年第3期78-86,共9页
Biotechnology & Business
基金
ISTIC-THOMSON科学计量学联合实验室开放基金资助
同被引文献32
-
1Sawzdargo M, George SR, Nguyen T, et al. A cluster of four novel human G protein-coupled receptor genes occurring in close prox- inity to CD22 gene on chromosome 19q13. 1 [ J ]. Biochem Biophys Res Commun, 1997,239:543-547.
-
2Basu A, Kudva Y C, Basu R. GPR40 Modulators : New kid on the block[ J ]. Diabetes Care ,2013,36 : 185-187.
-
3Tetsumori Yamashima. Dual effects of the non-esterified fatty acid receptor ' GPR40' for human health[ J]. 2015,48:40-50.
-
4Stefand D P, Itamar R. Introduction to the 4th world congress on Controversies to consensus in Diabetes, O-besity and Hypertension (CODHy) [ J ]. Diabet Care,2013,36 ( Suppl 2) : S111 -S112.
-
5Harada Shinichi, Huruna Yuka, Aizawa Fuka, et al. Involvement of GPR40, a long-Chain free fatty acid receptor in the production of central post-stroke pain after global cerebral ischemia [ J ]. Europ J Pharmac,2014 , 744 : 115-123.
-
6Nakamoto Kazuo, Aizawa Fuka, Nishinaka Takashi, et al. Regula-tion of Prohormone. Convertase 2 protein expression via GPR40/ FFA1 in the hypothalamus [ J ]. Europ J Pharmac, 2015,762 : 459-463.
-
7Abaraviciene S M, Muhammed S J, Amisten S, et al. GPR40 pro- tein levels are crucial to the regulation of stimulated hormone secretion in pancreatic islets. Lessons from spontaneous obesity- prone and non-obese type 2 diabetes in rats [ J]. Molecular and Cellular Endocrinology,2013,381 (1-2) : 150-159.
-
8Lu ZY, Li YC, Jin JF, et al. GPR40/FFA1 and neutral sphingo- myelinase are involved in palmitate-boosted inflammatory response of microvascular endothelial cells to LPS [ J ]. Atherosclerosis, 2015,240( 1 ) :163-173.
-
9Kristinsson H, Bergsten P, Sargsyan ES. Free fatty acid receptor1 (FFA1 R/GPR40)signaling affect insulin secretion by enhancing mitochondrial respiration during palmitate exposure [ J ]. Biochim et Biophy Acta-Molec Cell Res,2015,1853 (12) :3248-3257.
-
10Kruska N, Reiser G. Phytanic acid and pristanic acid, branched- chain fatty acids associated with Refusm diease and other inheri- ted peroxisomal disorders, mediate intracellular Ca2 + signaling through activation of free fatty acid receptor GPR40 [ J ]. Neurobiol Diea,2011 43(2) :465-472.
二级引证文献1
-
1巨世杰,魏朝,郭凯蕾,李琦,梁佳龙,马丽莎,张东旭,卫培峰,刘雪英.新型吖啶二酮类GPR40激动剂的结构优化和抗2型糖尿病的活性研究[J].中南药学,2023,21(4):917-923. 被引量：1
-
1毛开云,杨露,陈大明,江洪波.高血压治疗用药开发的发展态势分析[J].生物产业技术,2014(4):76-83.
-
2王恒哲,杨露,毛开云.肥胖治疗用药开发的发展态势分析[J].生物产业技术,2015(3):85-90. 被引量：3
-
3杨露,陈大明,毛开云.非小细胞肺癌治疗用药开发的发展态势分析[J].生物产业技术,2014(2):76-85. 被引量：2
-
4毛开云,杨露,陈大明.小细胞肺癌治疗用药开发的发展态势分析[J].生物产业技术,2014(1):77-84. 被引量：1
-
5杨露,毛开云,范月蕾.肾细胞癌治疗用药物开发的发展态势分析[J].生物产业技术,2016(4):71-78.
-
6张红绪,贾孟,周庆峰,张怡,李成伟.exendin-4表达载体构建及其在大肠杆菌中分泌表达[J].河南师范大学学报（自然科学版）,2009,37(2):109-112. 被引量：2
-
7张艳芳,吴汉妮.抵抗素与胰岛素抵抗[J].国外医学（分子生物学分册）,2003,25(5):297-299. 被引量：5
-
8杨露,苏琴,毛开云,范月蕾.全球肿瘤免疫治疗药物研发态势[J].生物产业技术,2016(3):85-90. 被引量：1
-
9赵爱民.生物信息技术发展态势分析[J].中国生物工程杂志,2003,23(5):101-103. 被引量：15
-
10Anil Kumar Mandal,Linda Marie Hiebert.Diabetes Mellitus： Too Many Controversies Affecting Care[J].Journal of US-China Medical Science,2013,10(5):121-127. 被引量：1
